Website Privacy Policy
This document sets out GSK's Website Privacy Policy for www.preventchickenpox.co.nz. This Website Privacy Policy is in addition to and should be read in conjunction with the terms and conditions which govern the use of this Website.
GSK recognises that your privacy is a closely held and highly personal value and that you have a right to control your personal information. We understand that providing personal information is an act of trust and you have our assurance that we will take all reasonable steps to ensure that the personal information you provide to us is protected from misuse or unauthorised disclosure. Information collected through this Website will be held by GSK in accordance with the principles of the New Zealand Privacy Act 1993 and the Health Information Privacy Code 1994.
Unless you explicitly direct us to act otherwise, this Website Privacy Policy will govern how GSK handles your personal information and safeguards your privacy.
Generally GSK will inform you when we collect personal information from you when you use the site. Apart from any information specifically requested of you and provided by you GSK collects the following information from users of this site:
This information is collected anonymously. If you have not identified yourself on the site, we will not link a record of your usage of our Website to you personally.
In some instances, the purpose for which this information is collected will be indicated when the information is collected.
GSK will only use personal information for the purpose for which it was collected or as may otherwise be permitted by law. GSK may use or disclose information about you to the extent:
GSK will not provide personal information about you to any third parties except:
GSK will take reasonable steps to keep secure any information which we hold about you, and to keep this information accurate and up to date. While GSK will endeavour to take all reasonable steps to keep secure any information which we hold about you, you acknowledge that the internet is inherently insecure and that GSK cannot provide any absolute assurance regarding the security of your personal information. You also acknowledge that GSK gives no assurance with regards to personal information being transmitted by you to GSK. GSK will not be liable in any way in relation to any breach of security or unintended loss or disclosure of information due to the Website being linked to the internet.
If we hold personal information about you, you are able to access, change and update your personal information at any time. If you wish to do this, please contact us using the feedback & inquiries form setting out your name and email address and the details of your request. We will acknowledge receipt of your request within 7 days and endeavour to respond to your request within 30 days.
From time to time the Website may contain links to other websites. GSK is not responsible for the privacy practices of the content of those websites. We strongly recommend that you examine the privacy policies of any linked website before disclosing your personal information on any such site.
GSK reserves the right to change this Website Privacy Policy at any time and notify you by posting an updated version of the policy on the Website.
We at GSK welcome your feedback. If you have any questions in relation to this Website Privacy Policy or GSK's privacy practices, or if you have any suggestions or problems, please contact us using the feedback & inquiries form. For general information on protecting your privacy, please visit the New Zealand Privacy Commissioner's website at www.privacy.org.nz.
Varilrix® (live attenuated varicella vaccine) is available as an injection. Varilrix is a private-purchase prescription medicine for immunisation and prophylaxis against varicella (chickenpox) in adults and children older than 9 months. You will need to pay for this medicine. Children aged 13 years and older need two doses with an interval between doses of at least 6 weeks. Two doses at least 6 weeks apart are also recommended for children aged between 9 months and 12 years, to provide optimal protection. Use strictly as directed. Do not have a Varilrix injection if you are allergic to Varilrix or to the antibiotic neomycin, if you have a high fever, if you have a condition that causes lack of immunocompetence, or if you are pregnant. Pregnancy should be avoided for 3 months after vaccination. Tell your doctor before you have the vaccine if you have a lowered resistance to disease or have a severe chronic disease. Common side effects: mild rash, a small number of chicken-pox-like blisters, or pain, redness and swelling at the injection site. Uncommon side effects include fever, headache, cough, vomiting, swollen lymph nodes, and joint pain. If you have any side effects, see your doctor, pharmacist, or health professional. Additional Consumer Medicine Information for Varilrix is available at www.medsafe.govt.nz. Prices for Varilrix may vary across doctor's clinics. Normal doctor's office visit fees apply. Ask your doctor if Varilrix is right for you.
Varilrix is a registered trade mark of the GlaxoSmithKline group of companies. Marketed by GlaxoSmithKline NZ Limited, Auckland.
Adverse events involving GSK products should be reported to GSK Medical Information on 0800 808 500.
Clicking this link will take you to an independent non GSK site that may contain content that does not necessarily reflect the views of GSK or the licenced indications for the use of GSK products.